Last reviewed · How we verify

NCT06215937

Quantitative Sensory Testing and Central Sensitization in Endometriosis

Recruiting now Last updated 7 August 2024
What this trial tests

trial testing No Intervention in Endometriosis in 90 participants. Currently enrolling.

Timeline
1 May 2024
Primary endpoint
31 January 2026
31 January 2026

Quick facts

Lead sponsorBC Women's Hospital & Health Centre
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment90
Start date1 May 2024
Primary completion31 January 2026
Estimated completion31 January 2026
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

BC Women's Hospital & Health Centre

Who can join

Adults 19 to 49, female only, with Endometriosis or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endometriosis is a gynecologic condition where there is growth of endometrial-like tissue outside the uterus, leading to severe pelvic pain. Despite conventional treatment, many patients experience persistent pelvic pain due to central sensitization (CS), where the central nervous system amplifies pain signals. Quantitative Sensory Testing (QST) enables objective testing of CS. However, there are several patient-reported questionnaires that have shown promising potential as subjective proxies of CS. Therefore, in this study, our objective is to validate six patient-reported questionnaires as measures of CS by comparing them to each other and determining whether each questionnaire correlates with QST thresholds.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No Intervention

Trials testing the same drug.

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other BC Women's Hospital & Health Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06215937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing